UNICA IRIS Institutional Research Information System

MACCIONI, ELIAS
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 303.409
NA - Nord America 10.842
AS - Asia 3.878
SA - Sud America 621
AF - Africa 147
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 318.910
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 300.309
US - Stati Uniti d'America 10.685
CN - Cina 1.828
SG - Singapore 1.388
UA - Ucraina 947
SE - Svezia 765
BR - Brasile 515
DE - Germania 457
FI - Finlandia 273
GB - Regno Unito 261
VN - Vietnam 187
FR - Francia 107
IN - India 100
KR - Corea 97
CA - Canada 94
MA - Marocco 74
HK - Hong Kong 54
NL - Olanda 47
RU - Federazione Russa 43
AR - Argentina 40
BD - Bangladesh 40
AT - Austria 39
MX - Messico 38
PL - Polonia 33
PK - Pakistan 27
ZA - Sudafrica 27
TR - Turchia 23
BE - Belgio 22
ES - Italia 21
IE - Irlanda 21
JP - Giappone 20
EC - Ecuador 19
ID - Indonesia 18
IQ - Iraq 17
CO - Colombia 14
IR - Iran 14
CZ - Repubblica Ceca 13
KE - Kenya 13
EG - Egitto 10
LT - Lituania 10
PY - Paraguay 10
UZ - Uzbekistan 9
CR - Costa Rica 8
PA - Panama 8
PT - Portogallo 8
SA - Arabia Saudita 8
TN - Tunisia 8
CL - Cile 7
EU - Europa 7
NP - Nepal 7
RO - Romania 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 5
IL - Israele 5
JO - Giordania 5
PE - Perù 5
ET - Etiopia 4
HU - Ungheria 4
KG - Kirghizistan 4
KZ - Kazakistan 4
MU - Mauritius 4
AL - Albania 3
AU - Australia 3
CH - Svizzera 3
KW - Kuwait 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GE - Georgia 2
HR - Croazia 2
IS - Islanda 2
MD - Moldavia 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
UY - Uruguay 2
A1 - Anonimo 1
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
CG - Congo 1
CM - Camerun 1
CU - Cuba 1
DZ - Algeria 1
GA - Gabon 1
GT - Guatemala 1
IM - Isola di Man 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MV - Maldive 1
MY - Malesia 1
RS - Serbia 1
Totale 318.907
Salva come PNG Salva come JPEG
Città #
Cagliari 294.374
Uta 5.289
Fairfield 990
Chandler 875
Ashburn 865
Woodbridge 848
Singapore 658
Dallas 653
Houston 645
Ann Arbor 531
Nyköping 529
Boardman 492
Jacksonville 492
Wilmington 411
Seattle 402
Beijing 391
Dearborn 378
Cambridge 303
New York 191
Los Angeles 180
Nanjing 169
Santa Clara 157
Shanghai 146
Boston 136
Hefei 132
Helsinki 124
Seoul 97
The Dalles 96
Buffalo 75
Redwood City 64
Casablanca 63
Ho Chi Minh City 58
Shenyang 58
Nanchang 54
Dong Ket 53
Munich 52
San Diego 51
Guangzhou 50
Toronto 48
Hong Kong 45
Milan 45
São Paulo 42
Hebei 41
Jiaxing 41
Verona 41
Changsha 40
Sassari 38
Amsterdam 34
Jinan 33
Tianjin 31
Warsaw 31
Mountain View 29
London 28
Redondo Beach 28
Kunming 27
Frankfurt am Main 25
Montreal 25
Hanoi 24
Herndon 24
Norwalk 24
Phoenix 24
Vienna 24
Chicago 23
Chennai 21
Brussels 20
Zhengzhou 20
Atlanta 19
Auburn Hills 18
Hangzhou 18
Washington 18
Brooklyn 17
Johannesburg 17
Orange 17
Taizhou 17
Tokyo 17
Dublin 16
Nuremberg 16
Pune 16
Ningbo 15
Rome 15
San Francisco 15
Wuhan 15
Council Bluffs 14
Columbus 13
Rio de Janeiro 13
Stockholm 12
Turku 12
Düsseldorf 11
Falls Church 11
Mumbai 11
Nairobi 11
Campinas 10
Denver 10
Mexico City 10
Brasília 9
Curitiba 9
Guarulhos 9
Jakarta 9
Manchester 9
Redmond 9
Totale 312.466
Salva come PNG Salva come JPEG
Nome #
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro- 1H -indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 14.687
Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida 5.025
Methoxyflavones from Stachys glutinosa with binding affinity to opioid receptors: in silico, in vitro, and in vivo studies 4.674
Phenylpropenoids from Bupleurum fruticosum as Anti-Human Rhinovirus Species A Selective Capsid Binders 4.652
Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase 4.628
Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase 4.481
Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors 4.405
Quercetin blocks Ebola Virus infection by counteracting the VP24 Interferon inhibitory function 4.397
2-(2-cycloalkylidene hydrazin-1-yl)-4-aryl-1,3-thiazoles: a promising class of antifungal agents 4.344
Lactoferrin- and antitransferrin-modified liposomes for brain targeting of the NK3 receptor agonist senktide: Preparation and in vivo evaluation 4.334
Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6 4.290
3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles: A new scaffold for the selective inhibition of monoamine oxidase B 4.273
Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase 4.142
N-Alkyl dien- and trienamides from the roots of Otanthus maritimus with binding affinity for opioid and cannabinoid receptors 3.908
New 4-[(3-cyclohexyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzene-1-sulfonamides, synthesis and inhibitory activity toward carbonic anhydrase I, II, IX, XII 3.897
Drug design, synthesis, in vitro and in silico evaluation of selective monoaminoxidase B inhibitors based on 3-acetyl-2-dichlorophenyl-5-aryl-2,3-dihydro-1,3,4-oxadiazole chemical scaffold 3.733
A novel series of 3,4-disubstituted dihydropyrazoles: Synthesis and evaluation for MAO enzyme inhibition 3.730
Identification of Myricetin as Ebolavirus VP35-dsRNA interaction inhibitor through a novel fluorescence-based assay 3.707
Ferulic Acid Esters and Withanolides: in Search of Withania somnifera GABAA Receptor Modulators 3.551
Targeting tumor associated carbonic anhydrase IX and XII: Highly isozyme selective coumarin and psoralen inhibitors 3.505
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 3.432
Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication 3.394
Coumarins from Magydaris pastinacea as inhibitors of the tumour-associated carbonic anhydrases IX and XII: isolation, biological studies and in silico evaluation 3.375
N-alkylamides from Otanthus maritimus: structure elucidation, binding affinity for cannabinoid receptors and computational study 3.361
Through scaffold modification to 3,5-diaryl-4,5-dihydroisoxazoles: new potent and selective inhibitors of monoamine oxidase B 3.332
Molecular Aspects of the RT/drug Interactions. Perspective of Dual Inhibitors 3.277
Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors 3.266
Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action 3.260
Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B 3.226
Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase 3.176
N-Acylbenzenesulfonamide dihydro-1,3,4-oxadiazole hybrids: seeking selectivity toward carbonic anhydrase isoforms 3.154
Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors 3.061
Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques 3.040
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Dual Inhibitors of HIV-1 RT. 3.002
Investigating the Anticancer Activity of Isatin/Dihydropyrazole Hybrids 2.987
Tuning the Dual Inhibition of Carbonic Anhydrase and Cyclooxygenase by Dihydrothiazole Benzensulfonamides 2.982
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) enlighten the mechanism of action of a new Ribonuclease H/DNA polymerase RT dual inhibitor 2.931
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Single Site Dual Inhibitors of HIV-1 RT 2.878
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) shed light on the mechanism of action of a new Ribonuclease H/ DNA polymerase RT dual inhibitor 2.869
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 2.816
Mutagenic study on HIV-1 reverse transcriptase to explore the mechanism of action of HIV-1 reverse transcriptase dual inhibitors 2.737
MD protocol validation for the study of MAOB-inhibitor complexes 2.736
In search of new antitumor agents through the combination of individually active moieties: construction of a [3,5-diaryl-(4,5- dihydropyrazol-1-yl)-4-oxo-1,3-thiazol-5-ylidene]- 1H-indol-2-ones library 2.705
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity 2.694
Synthesis and biological activity evaluation of new dual-inhibitors of both associated functions of HIV-1 RT 2.595
Structure-based virtual screening of novel natural alkaloid derivatives as potential binders of h-telo and c-myc DNA G-quadruplex conformations 2.594
3-[2-(4-aryl-1,3-thiazol-2-yl)hydrazin-1-ylidene]-1H-indol-2-ones as new potential dual inhibitors of polimerase and ribonuclease HIV-1 RT associated function 2.579
Towards the total block of HIV-1 Reverse Transcriptase: the dual-inhibitors approach 2.571
Exploring new structural features of the 4-[(3-methyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzenesulphonamide scaffold for the inhibition of human carbonic anhydrases 2.514
Investigation on the mechanism of action of new dual inhibitors of HIV-1 RT 2.503
Synthesis and characterization of new phthalhydrazothiazole derivatives: A preliminary investigation on their activity against hepatocellular carcinoma 2.489
Chalcones as novel dual inhibitors of HIV-1 reverse transcriptase 2.415
Meeting report: Fourth Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS) 2.402
New dual inhibitors of RT associated functions: investigation on their mechanism and mode of action 2.390
New promising scaffolds for the inhibition of monoamine oxidase B 2.268
Hit Identification of a Novel Dual Binder for h-telo/c-myc G-Quadruplex by a Combination of Pharmacophore Structure-Based Virtual Screening and Docking Refinement 2.255
Exploring new scaffolds for the inibition of the Ribonuclease H function of RT HIV-1 2.217
Terapia delle infezioni sostenute da Candida spp.: nuovi approcci mediante derivati isotiosemicarbazonici. 2.134
Isatin derivatives as new scaffolds for HIV-1 reverse transcriptase associated RNase H and RDDP dual inhibitors 2.096
Meeting report: Third Summer School on innovative approaches for identification of antiviral agents (IAAASS) 2.085
In vitro activity of 2-cyclohexylidenhydrazo-4-phenil-thiazole compared with those of amphotericin b and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans 2.071
Design, synthesis and biolgical activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 2.043
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 2.033
Design, synthesis and biological activity evaluation of c-myc proto-oncogene binders as potential antitumor agents 2.031
null 1.949
Design, synthesis and biological activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.929
Synthesis and anti-microbial activity evaluation of some new 1-benzoyl-isothiosemicarbazides. 1.897
New reactions of carbon suboxide with alkines 1.893
Identification of HIV-1 reverse trascriptase dual inhibitors by a combined shape-, 2D fingerprint and pharmacophore-based virtual screening approch 1.891
Semipreparative HPLC enantioseparation, chiroptical properties, and absolute configuration of two novel cyclooxygenase-2 inhibitors 1.863
Design of new inhibitors of the HIV-1 Reverse Transcriptase associated Ribonuclease H function: a synthetic approach 1.846
Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors 1.838
Brain delivery of the NK3 receptor agonist senktide by immunoliposome: an in vivo microdialysis study 1.790
Identification of new scaffolds for the inhibition of HIV-1 Reverse Transcriptase associated Ribonuclease H function by means of shape based similarity screening 1.764
SITE DIRECT MUTAGENESIS AND KINETIC STUDIES TO EXPLORE THE MECHANISM OF ACTION OF ISATIN DERIVATIVES AS HIV-1 REVERSE TRANSCRIPTASE DUAL INHIBITORS 1.755
Application of an immobilised amylose-based chiral stationary phase to the development of new monoamine oxidase B inhibitors 1.745
New Dihydrothiazole Benzensulfonamides: Looking for Selectivity toward Carbonic Anhydrase Isoforms I, II, IX, and XII 1.692
Exploring new scaffolds for the inhibition of the Ribonuclease H function of RT HIV-1 1.669
SYNTHESIS, MOLECULAR MODELLING, INHIBITORY ACTIVITY, AND SELECTIVITY TOWARDS MONOAMINE OXIDASE OF NEW HETEROCYCLIC SCAFFOLDS 1.655
Synthesis and anti-microbial activity of isothiosemicarbazones and cyclic analogues 1.634
Synthesis and antimicrobial activity of novel arylidenisothiosemicarbazones 1.629
Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1: a patent survey 1.602
Flavonoids and Acid-Hydrolysis derivatives of Neo-Clerodane diterpenes from Teucrium flavum subsp. glaucum as inhibitors of the HIV-1 reverse transcriptase–associated RNase H function 1.579
Synthesis and biological evaluation of new dual inhibitors of HIV-1 associated functions 1.578
Effetti sulla attività di AmB nei confronti di biofilm di C. albicans in seguito ad esposizione a EM01D2 e fluconazolo. 1.557
From classic to innovative approaches in HIV-1 infection treatment 1.521
null 1.499
Derivati ciclici isotiosemicarbazonici come approccio alternativo nella terapia delle infezioni sostenute da Candida spp. 1.433
null 1.415
null 1.406
Shape based computer aided similarity screening: a valid tool in the discovery of new scaffolds for the inhibition of HIV-1 reverse transcriptase associated ribonuclease H function 1.381
Identification of G-quadruplex DNA/RNA binders: Structure-based virtual screening and biophysical characterization 1.296
The preparation of non ionic surfactant vesicles formed from hexacyclophosphazenic derivatives 1.256
9-fluorenones as new scaffolds for G-quadruplex DNA 1.196
Synthesis of new arylidencycloalkylpyrazoles of potential biological interest 1.148
Exploring new scaffolds for the dual inhibition of HIV-1 RT polymerase and ribonuclease associated functions 1.136
A combined shape-, 2D-fingerprint-and pharmacophore-based virtual screening for the identification of dual inhibitors targeting HIV-1 reverse transcriptase. 1.130
An investigation of the biological effect of structural modifications of isothiosemicarbazones and their cyclic analogues 1.089
Design, synthesis and biological evaluation of new fluorenone derivatives as DNA G-quadruplex binders 1.081
Synthesis, molecular modelling, inhibitory acivity, and selectivity towards monoamine oxidase of new heterocyclic scaffold 1.080
Totale 270.161
Salva come PNG Salva come JPEG
Categoria #
all - tutte 375.758
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 375.758
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132.342 0 0 0 0 0 8.290 6.218 4.614 1.996 4.479 4.401 2.344
2021/202214.008 1.700 1.214 707 981 1.186 930 870 734 1.327 1.365 1.419 1.575
2022/202323.332 2.103 3.454 2.892 2.226 1.572 2.521 1.290 1.647 1.248 1.333 1.869 1.177
2023/202422.577 1.096 695 2.080 1.828 2.344 3.929 2.885 1.628 1.203 1.336 1.657 1.896
2024/202549.847 15.268 14.318 6.700 4.383 2.091 2.671 2.480 205 516 346 344 525
2025/20264.811 802 459 1.439 1.138 908 65 0 0 0 0 0 0
Totale 319.439